.. he wasn't certain, though, how much he'd be able to work before then.
.
.
why novartis� landmark cancer drug approval is great news for bluebird
.
.
.
.
.
the total amount paid out in critical illness claims was £75.19m, with cancer accounting for 74 per cent of claims from women, mainly breast cancer, alongside 51 per cent from men.